GlassScriptPhysician profile
Jeffrey Turner
NPI 1942543004
$32,060.57
in general payments reported to CMS, 2019-2025
33 companies · $4,511 in 2025
The $4,511 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,209 · 2020: $1,550 · 2021: $3,344 · 2022: $7,917 · 2023: $3,510 · 2024: $6,020 · 2025: $4,511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $3,463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,576.91 |
| Travel and Lodging | $3,463.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $8,656.81 | 2019-2025 | Watchman Flx, Watchman Access System, Rhythmia Mapping System |
| Abbott Laboratories | $6,466.27 | 2021-2025 | Aveir, Optis, Gallant |
| Cook Incorporated | $6,061.39 | 2022 | |
| Biosense Webster, INC. | $4,733.52 | 2019-2025 | Carto 3, Soundstar, Na |
| Medtronic, INC. | $2,183.24 | 2021-2025 | Pulseselect, Affera Mapping System, Concertotm |
| Medtronic Vascular, INC. | $1,838.67 | 2019 | |
| Cardiva Medical, INC. | $513.46 | 2021-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Abiomed | $187.58 | 2021-2025 | Impella |
| Janssen Pharmaceuticals, INC | $169.50 | 2021-2024 | Xarelto |
| Pfizer INC. | $165.68 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $111.04 | 2022-2025 | Camzyos, Eliquis |
| Novo Nordisk INC | $109.77 | 2024-2025 | Wegovy |
| Edwards Lifesciences Corporation | $102.97 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Atricure, INC. | $95.64 | 2025 | Atriclip Laa Exclusion System, Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax |
| Biotronik INC. | $88.31 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $86.54 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| W. L. Gore & Associates, INC. | $63.96 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $60.22 | 2021-2023 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.95 | 2022-2023 | Jardiance |
| Esperion Therapeutics, INC. | $39.85 | 2022-2024 | Nexletol |
| Chiesi USA, INC. | $37.60 | 2024-2025 | Kengreal |
| Actelion Pharmaceuticals US, INC. | $37.18 | 2023-2024 | Opsumit, Uptravi |
| Bayer Healthcare Pharmaceuticals INC. | $30.46 | 2022-2025 | |
| Cvrx, INC. | $30.18 | 2021 | |
| Cordis US Corp. | $24.00 | 2025 | |
| Scpharmaceuticals INC. | $19.50 | 2024 | |
| Bridgebio Pharma, INC. | $18.38 | 2025 | Attruby |
| Irhythm Technologies, INC. | $18.37 | 2022 | |
| Teleflex LLC | $18.13 | 2025 | Guideliner |
| Philips North America LLC | $17.59 | 2024 | (Cm9) Amb Mon & Diag Und |
| Lexicon Pharmaceuticals, INC. | $14.54 | 2023 | Inpefa |
| Alnylam Pharmaceuticals INC. | $13.12 | 2021 | |
| Cook Medical LLC | $5.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.